After stopping GLP-1s, hunger-promoting hormones can increase while energy expenditure may dip slightly, a pairing that can promote weight gain
Probably the game-changing study in the New England Journal, which I was corresponding author on, was STEP 1, which actually launched semaglutide to the world which for the first time caused a result in a 15% weight loss at the end of a year
This landmark study builds on more than 20 years of research in obesity, a serious chronic disease associated with severe co-morbidities and outcomes, Martin Langue, executive vice president and head of development at Novo Nordisk, said in a statement
UK Medical Guidance and Regulatory Perspective In the UK, NICE guidance for type 2 diabetes (NG28) and obesity management (TA1026) does not specifically address cannabis use in conjunction with GLP-1 receptor agonists like tirzepatide
Aim to train all major muscle groups over the week: legs (squats, lunges), pushing muscles (chest, shoulders, triceps e.g., wall push-ups or dumbbell presses), pulling muscles (back, biceps e.g., dumbbell rows or resistance band pulls), and core (abdominals and lower back)
The current focus of research is on the treatment of obesity with long-acting non-precipitating amylin analogues that provide varying selectivity for the different AMY receptors
